Daniell Richard Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
35
Insider Sells Sum
$15.44M

Insider Activity of Daniell Richard

According to the SEC Form 4 filings, Daniell Richard, being in a position of

  1. EVP, Europe Commercial at Teva Pharmaceutical Industries Limited,
    оver the last 12 months, has bought 0 shares, and sold 349581 share for $10.99M,
    over all time since 2018-03-05, has bought 0 shares, and sold 1501567 shares for $26.43M.

Biography of Daniell Richard

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $10,990,3395100

Comparison of Insiders on Amount of Buys and Sells

2026-05-05SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Europe Commercial
30,000
0.0025%
$35.40$1.06M+0.47%
2026-03-05SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Europe Commercial
17,295
0.0015%
$31.67$547,705+9.09%
2026-03-04SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Europe Commercial
57,833
0.005%
$32.78$1.9M+5.23%
2026-03-03SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Europe Commercial
128,985
0.0108%
$32.36$4.17M+7.25%
2025-12-09SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
115,468
0.0101%
$28.68$3.31M+19.22%
2025-03-05SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
37,123
0.0032%
$15.91$590,746+16.04%
2025-03-05SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
108,084
0.0094%
$15.91$1.72M+16.04%
2025-03-05SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
70,961
0.0062%
$15.91$1.13M+16.04%
2025-03-04SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
12,936
0.0011%
$15.56$201,253+17.14%
2025-03-04SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
104,544
0.009%
$15.71$1.64M+17.14%
2025-03-04SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
91,608
0.0079%
$15.73$1.44M+17.14%
2025-03-03SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
49,314
0.0044%
$16.19$798,172+14.88%
2024-08-12SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
98,943
0.0088%
$17.30$1.71M+0.03%
2024-03-05SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
48,629
0.0043%
$13.52$657,240+25.89%
2024-03-04SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
33,512
0.003%
$13.34$446,960+26.82%
2024-02-28SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
20,599
0.0018%
$13.12$270,176+30.1%
2023-03-07SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
54,007
0.0048%
$9.43$509,173-1.96%
2023-03-06SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
18,002
0.0016%
$9.93$178,776-6.61%
2023-02-28SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
44,252
0.004%
$9.89$437,502-6.66%
2022-03-04SaleTeva Pharmaceutical Industries Limited
TEVA
Exec. VP, European Commercial
56,832
0.0051%
$7.48$425,245+19.03%
Total: 40
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.